Nova Max Creat eGFR Monitoring System
FDA 510(k) clearance K251281 · decided 2026-01-21
Clearance details
- K-number
- K251281
- Device name
- Nova Max Creat eGFR Monitoring System
- Applicant
- Nova Biomedical Corporation
- Decision
- Substantially Equivalent
- Date received
- 2025-04-24
- Decision date
- 2026-01-21
- Days to decision
- 272 days
- Clearance type
- Traditional
- Product code
- SHB
- Device class
- 2
- Regulation number
- 862.1225
- Medical specialty
- Clinical Chemistry
- Advisory committee
- Clinical Chemistry
- Location
- Walham, MA, US
- Third-party review
- No
- Expedited review
- No
+ Add to Predicate Builder ◉ Watch Nova Biomedical Corporation
Need this as data, not a web page?
Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.
Recalls involving this device
No recalls on record reference this clearance.